Resources

Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C

Showing 1 to 10 of 70 resources

  • Guidance for Blood Borne Virus services within Community Drug & Alcohol Services in the East of England
    This document, produced by the East of England Viral Hepatitis Group, forms part of a wider toolkit for community drug and alcohol services in the East of England, and aims to (a) enable compliance with Public Health Law and (b) to protect the East of England population from the consequences of hepatitis B & C by agreeing a clear care pathway with Community Drug & Alcohol Services (CDAS) in the region.
    England, East of England Apr 2017 Strategy & Planning PDF
  • Hepatitis C in England 2017 report
    This report by Public Health England has been produced to support monitoring of the recently agreed Global Health Sector Strategy on Viral Hepatitis goals, including the elimination of hepatitis C as a major public health threat by 2030. The report summarises the impact of action plans in England to drive down mortality from hepatitis C, reduce the number of new infections, and outlines the actions required to make further progress.
    England Mar 2017 Reports & Research, Strategy & Planning PDF
  • Guidelines on hepatitis B and C testing
    These are the first WHO guidelines on testing for chronic hepatitis B and C infection and complement published guidance by WHO on the prevention, care and treatment of chronic hepatitis C and hepatitis B infection. These guidelines outline the public health approach to strengthening and expanding current testing practices for hepatitis B and C, and are intended for use across age groups and populations.
    Rest of World Feb 2017 Other, Strategy & Planning PDF
  • National Clinical Guidelines for the treatment of HCV in adults
    These Scottish guidelines, updated in January 2016, provide expert guidance to Health Boards, Area Drug and Therapeutics Committees, and treating clinicians on the efficacy of available treatments for hepatitis C. They also act as a clinical reference source for NHS National Procurement to produce rankings on cost-effectiveness. Development of the guidance was a collaboration between Scotland's viral hepatitis clinical leads and MCN co-ordinators network, National Services Scotland, and Healthcare Improvement Scotland.
    Scotland Jan 2017 Other, Strategy & Planning PDF
  • HCV Action and PHE hepatitis C roadshow in Manchester: Presentations
    On 13th December 2016, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in Manchester. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in Manchester and the wider north west region.
    UK, England, North West Other, Strategy & Planning PDF
  • Hepatitis C Commissioning Toolkit
    The Hepatitis C Commissioning Toolkit, an update to the original toolkit published in September 2013, sets out key commissioning responsibilities, with the intention of bringing clarity to an often highly fragmented commissioning landscape. The toolkit is also intended to aide commissioners in commissioning cost-effective services which are tailored to the needs of people with hepatitis C, by setting out how to ensure a clear, connected and properly funded hepatitis C care pathway, as well as providing good practice examples.
    England Case study, Tools & Templates, Strategy & Planning PDF
  • Working Together to Reduce Harm (Substance Misuse) Delivery Plan 2016 - 2018
    This Welsh Government delivery plan describes the work that will be undertaken reduce the harm caused by substance misuse. It includes actions related to hepatitis C such as the implementation of routine opt-out testing in substance misuse services.
    UK, Wales Sep 2016 Strategy & Planning PDF
  • Hepatitis C among drug users in Europe: Epidemiology, treatment and prevention
    This report, produced by the European Monitoring Centre for Drugs and Drug Addiction, provides an overview of the epidemiology of hepatitis C in Europe. It contains chapters on issues such as providing hepatitis C treatment to people who inject drugs, strategies to improve hepatitis C care and increasing uptake of treatment among people who inject drugs, and hepatitis C prevention among people who inject drugs.
    UK, Rest of World Aug 2016 Reports & Research, Strategy & Planning PDF
  • HCV Action and PHE hepatitis C roadshow in Newcastle: Presentations
    On 17th May 2016, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in Newcastle. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in Newcastle and the wider north east region.
    North East, UK, England Jun 2016 Other, Strategy & Planning PDF
  • WHO Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection
    These guidelines, developed by the World Health Organisation, promote the transition to newer, more effective medicines that have the potential to cure most persons living with hepatitis C infection. They also provide guidance on which specific regimens should be used based on a patient’s clinical history as well as genotype, and are intended to promote the scale-up of hepatitis C treatment.
    UK, Rest of World Apr 2016 Other, Strategy & Planning PDF

Pages